Adenosine also decreases tumor-derived extracellular adenosine via respiratory hyperoxia or coinhibition of CD73 where A2aR could improve the antitumor immune responses by enhancing the cytotoxic capacity of CD8+ T and natural killer (NK) cells [11–13]. The gene discussed is ADORA2A; the disease is neoplasm.